During the past decade, Osaka Habikino Medical Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Habikino Medical Center" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Japan Clinical Oncology Group" with 2 trials sponsored and "Chugai Pharmaceutical" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Habikino Medical Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Habikino Medical Center" are "Atopic Dermatitis" (3 trials), "Dermatitis, Atopic" (3 trials), "Eczema" (3 trials), "Dermatitis" (2 trials) and "Skin Diseases" (2 trials). Many other conditions were trialed in "Osaka Habikino Medical Center" in a lesser frequency.

Most popular intervention types in "Osaka Habikino Medical Center" are "Drug" (15 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Carboplatin" (3 trials), "Atezolizumab" (2 trials), "Baricitinib" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Habikino Medical Center" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Osaka Habikino Medical Center". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Osaka Habikino Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Habikino Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".